Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

Mesoblast Ltd: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

25 Jul 2015 Reuters Investment Profile 12 $20.00

Thomson Reuters Stock Report - Mesoblast Ltd (MSB-AU)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

30 Jul 2015 Thomson Reuters Stock Report 11 $25.00

Mesoblast limited: Upgraded to Average

29 Jul 2015 Sadif Analytics Prime 3 $10.00

ValuEngine Industry Report for Medical-Biomed/Genetics(MBLTY)

Advanced academic research that brings you superior investment strategies in an actionable format. Industry Analysis Report, ...

28 Jul 2015 ValuEngine, Inc. 10 $49.00

Wright Investors Service Comprehensive Report for Mesoblast Ltd

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio table...

24 Jul 2015 Wright Reports 55 $75.00

MESOBLAST - HEADWAY ON POSITIVE DEVELOPMENTS

Mesoblast is steadily advancing its pipeline, presenting positive Phase II data at the American Diabetes Association in June ...

23 Jul 2015 Edison Investment Research 6 $10.00

Mesoblast Limited - Type 2 Diabetes Trial Results Published in Diabetes Care

23 Jul 2015 irasia.com 2 $23.00

ValuEngine Industry Report for Medical-biomed/genetics(MBLTY)

Advanced academic research that brings you superior investment strategies in an actionable format. Industry Analysis Report, ...

21 Jul 2015 ValuEngine, Inc. 10 $49.00

Mesoblast Limited - Congestive Heart Failure Phase 2 Trial Results Published in Circulation Research

15 Jul 2015 irasia.com 2 $23.00

Mesoblast Limited - Appendix 3Y - Change of Director's Interest Notice - Mr. Donal O'Dwyer

13 Jul 2015 irasia.com 3 $35.00